Mehrdad Nadji

7.3k total citations
169 papers, 5.6k citations indexed

About

Mehrdad Nadji is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mehrdad Nadji has authored 169 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 45 papers in Molecular Biology and 29 papers in Cancer Research. Recurrent topics in Mehrdad Nadji's work include Molecular Biology Techniques and Applications (18 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Ovarian cancer diagnosis and treatment (13 papers). Mehrdad Nadji is often cited by papers focused on Molecular Biology Techniques and Applications (18 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Ovarian cancer diagnosis and treatment (13 papers). Mehrdad Nadji collaborates with scholars based in United States, Hungary and Iran. Mehrdad Nadji's co-authors include Azorides R. Morales, Neal S. Penneys, Carmen Gomez‐Fernandez, Mehdi Nassiri, Parvin Ganjei‐Azar, Vladimir Vincek, Parvin Ganjei, Mercè Jordà, Hervy E. Averette and Albert Castro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mehrdad Nadji

162 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mehrdad Nadji United States 41 1.7k 1.6k 1.0k 1.0k 956 169 5.6k
Fadi W. Abdul‐Karim United States 43 1.6k 0.9× 1.5k 0.9× 960 0.9× 1.9k 1.9× 1.8k 1.9× 230 7.0k
Stefania Staibano Italy 43 2.4k 1.4× 2.8k 1.8× 725 0.7× 915 0.9× 1.2k 1.3× 229 6.5k
A M Gown United States 46 1.7k 1.0× 2.3k 1.4× 1.3k 1.2× 1.9k 1.9× 1.8k 1.9× 82 9.0k
Luis Chiriboga United States 48 1.6k 0.9× 2.2k 1.4× 1.2k 1.1× 1.3k 1.2× 985 1.0× 140 7.5k
Kenneth R. Shroyer United States 48 1.8k 1.0× 2.3k 1.4× 1.1k 1.1× 927 0.9× 924 1.0× 167 6.1k
Ossama Tawfik United States 45 2.0k 1.1× 2.5k 1.6× 795 0.8× 998 1.0× 890 0.9× 216 6.5k
Rex C. Bentley United States 49 1.6k 0.9× 2.7k 1.7× 885 0.8× 1.8k 1.7× 860 0.9× 163 8.5k
Ulrich Schwab United Kingdom 13 2.1k 1.2× 2.2k 1.4× 680 0.7× 891 0.9× 979 1.0× 32 7.3k
M. Duchrow Germany 31 1.6k 0.9× 1.8k 1.1× 648 0.6× 1.0k 1.0× 803 0.8× 60 5.3k
Fabien Calvo France 45 2.3k 1.3× 3.3k 2.1× 547 0.5× 534 0.5× 606 0.6× 160 6.7k

Countries citing papers authored by Mehrdad Nadji

Since Specialization
Citations

This map shows the geographic impact of Mehrdad Nadji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehrdad Nadji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehrdad Nadji more than expected).

Fields of papers citing papers by Mehrdad Nadji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehrdad Nadji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehrdad Nadji. The network helps show where Mehrdad Nadji may publish in the future.

Co-authorship network of co-authors of Mehrdad Nadji

This figure shows the co-authorship network connecting the top 25 collaborators of Mehrdad Nadji. A scholar is included among the top collaborators of Mehrdad Nadji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehrdad Nadji. Mehrdad Nadji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tjendra, Youley, Katherine Drews‐Elger, Yiqin Zuo, et al.. (2024). Atypia of undetermined significance and ThyroSeq v3–positive call rates as quality control metrics for cytology laboratory performance. Cancer Cytopathology. 132(8). 481–490.
2.
O’Hara, Todd M., Debra L. Miller, Gregory D. Bossart, et al.. (2023). A note on the possibility of identifying Leydig and Sertoli cells by immunohistochemistry in bowhead whales (Balaena mysticetus). ˜The œjournal of cetacean research and management. Special issue. 4(2). 149–153.
3.
Cavallin, Lucas E., Qi Ma, Sachin Gupta, et al.. (2018). KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis. PLoS Pathogens. 14(7). e1007175–e1007175. 29 indexed citations
4.
Koru‐Sengul, Tulay, Feng Miao, Olveen Carrasquillo, et al.. (2016). Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency. Clinical Gastroenterology and Hepatology. 14(8). 1163–1171. 22 indexed citations
5.
Nadji, Mehrdad, et al.. (2015). The Immunophenotype of Nodular Variant of Medullary Carcinoma of the Breast. Applied immunohistochemistry & molecular morphology. 23(9). 624–627. 1 indexed citations
6.
Szalontay, Luca, Ronald J. Benveniste, Andrew V. Schally, et al.. (2012). Inhibitory Effects of GHRH Antagonists on Human GH-Secreting Adenoma Tissue. Neuroendocrinology. 96(1). 81–88. 5 indexed citations
7.
Rick, Ferenc G., Luca Szalontay, Andrew V. Schally, et al.. (2012). Combining Growth Hormone-Releasing Hormone Antagonist With Luteinizing Hormone-Releasing Hormone Antagonist Greatly Augments Benign Prostatic Hyperplasia Shrinkage. The Journal of Urology. 187(4). 1498–1504. 32 indexed citations
8.
Meymandi, Simin Shamsi, Abdolreza Javadi, Shahriar Dabiri, Manzumeh Shamsi Meymandi, & Mehrdad Nadji. (2011). Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.. PubMed. 14(4). 238–43. 19 indexed citations
9.
Nadji, Mehrdad, Andrew V. Schally, Balázs Dezsö, et al.. (2010). Receptors for luteinizing hormone‐releasing hormone (LHRH) in benign prostatic hyperplasia (BPH) as potential molecular targets for therapy with LHRH antagonist cetrorelix. The Prostate. 71(5). 445–452. 14 indexed citations
10.
Haines, G. Kenneth, Elizabeth L. Wiley, Barbara Susnik, et al.. (2008). HER2 in well differentiated breast cancer: is testing necessary?. Breast Cancer Research and Treatment. 112(3). 551–556. 13 indexed citations
11.
Nassiri, Mehdi & Mehrdad Nadji. (2006). Molecular-Friendly Histopathology. Iranian journal of pathology. 1(1). 1–6. 1 indexed citations
12.
Cleary, Timothy J., Azorides R. Morales, Mehrdad Nadji, Mehdi Nassiri, & Vladimir Vincek. (2004). Antimicrobial activity of UMFix tissue fixative. Journal of Clinical Pathology. 58(1). 22–25. 4 indexed citations
13.
Berman, Brian, et al.. (2003). Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. British Journal of Dermatology. 149(s66). 59–61. 68 indexed citations
14.
Jordà, Mercè, et al.. (2002). Her2 expression in prostatic cancer: a comparison with mammary carcinoma.. PubMed. 168(4 Pt 1). 1412–4. 32 indexed citations
15.
Hanly, Andrew, George W. Elgart, Mercè Jordà, Jon Smith, & Mehrdad Nadji. (2000). Analysis of thyroid transcription factor‐1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. Journal of Cutaneous Pathology. 27(3). 118–120. 119 indexed citations
16.
Jordà, Mercè, Parvin Ganjei, & Mehrdad Nadji. (1994). Retrospective c‐erbB‐2 immunostaining in aspiration cytology of breast cancer. Diagnostic Cytopathology. 11(3). 262–265. 13 indexed citations
17.
Nadji, Mehrdad, et al.. (1986). Intestinal-Type Adenocarcinoma of the Gallbladder. The American Journal of Surgical Pathology. 10(1). 19–25. 36 indexed citations
18.
Nadji, Mehrdad, et al.. (1981). Kaposi's sarcoma: immunohistologic evidence for an endothelial origin.. PubMed. 105(5). 274–5. 117 indexed citations
19.
Nadji, Mehrdad, et al.. (1979). Fine needle aspiration cytology in gynecologic oncology. II. Morphologic aspects.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(5). 380–8. 32 indexed citations
20.
Lynne, Charles M., et al.. (1979). Renal angiomyolipoma; polycystic kidney, and renal cell carcinoma in patient with tuberous sclerosis. Urology. 14(2). 174–176. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fadi W. Abdul‐Karim Breakdown of academic impact, for papers by Stefania Staibano Breakdown of academic impact, for papers by A M Gown Breakdown of academic impact, for papers by Luis Chiriboga Breakdown of academic impact, for papers by Kenneth R. Shroyer Breakdown of academic impact, for papers by Ossama Tawfik Breakdown of academic impact, for papers by Rex C. Bentley Breakdown of academic impact, for papers by Ulrich Schwab Breakdown of academic impact, for papers by M. Duchrow Breakdown of academic impact, for papers by Fabien Calvo
Rankless by CCL
2026